| 3D Homology model of Sigma1 receptor E Laurini, D Marson, M Fermeglia, S Pricl Sigma Proteins: Evolution of the Concept of Sigma Receptors, 27-50, 2017 | 15 | 2017 |
| A dual targeting dendrimer-mediated siRNA delivery system for effective gene silencing in cancer therapy Y Dong, T Yu, L Ding, E Laurini, Y Huang, M Zhang, Y Weng, S Lin, ... Journal of the American Chemical Society 140 (47), 16264-16274, 2018 | 179 | 2018 |
| A Molecular Dynamics approach to investigate the tribological behaviour of Al-Si and α-Al2O3-Si interfaces at the nanoscale A Mio, D Marson, E Laurini, S Pricl, M Fermeglia, M Perčić, S Zelenika Introduction For more information, get in touch with Andrea Mio at amio …, 2022 | | 2022 |
| A self-assembling amphiphilic dendrimer nanotracer for SPECT imaging L Ding, Z Lyu, A Tintaru, E Laurini, D Marson, B Louis, A Bouhlel, ... Chemical Communications 56 (2), 301-304, 2020 | 26 | 2020 |
| Abstract C153: Rare BRAF mutations in menlanoma and beyond: Rationalizing the afficacy of B-raf inhibitors via HPC-based in silico/in vitro investigations S Pricl, E Laurini, D Marson, G Cavalieri Molecular Cancer Therapeutics 22 (12_Supplement), C153-C153, 2023 | | 2023 |
| An ionizable supramolecular dendrimer nanosystem for effective siRNA delivery with a favorable safety profile D Dhumal, W Lan, L Ding, Y Jiang, Z Lyu, E Laurini, D Marson, A Tintaru, ... Nano Research 14, 2247-2254, 2021 | 27 | 2021 |
| Another Brick in the Wall. Validation of the σ1 Receptor 3D Model by Computer-Assisted Design, Synthesis, and Activity of New σ1 Ligands E Laurini, D Marson, V Dal Col, M Fermeglia, MG Mamolo, D Zampieri, ... Molecular pharmaceutics 9 (11), 3107-3126, 2012 | 53 | 2012 |
| Approccio di ingegneria molecolare per lo studio della farmaco-resistenza nella terapia oncologica E Laurini, V Dal Col, D Marson, P Posocco, M Fermeglia, E Tamborini, ... Convegno Nazionale GRICU, 1-1, 2012 | | 2012 |
| Aquasomes: a novel nanocarrier system for drug delivery D Marson, M Russi, E Laurini, S Pricl Advanced and Modern Approaches for Drug Delivery, 281-299, 2023 | | 2023 |
| Azacalixphyrin nanostructures D Ferry, S Pricl, D Marson, Z Chen, G Canard, S Pascal, A Tintaru, O Siri Journal of Porphyrins and Phthalocyanines, 2023 | 1 | 2023 |
| Beyond the Veil: Free Energy Profiles and Partition Coefficients for Antimelanoma Drugs in Self-Assembled Nanomicelles via COSMOmic and Atomistic Molecular Dynamics Simulations A Mio, D Marson, G Cavalieri, M Fermeglia, E Laurini, S Pricl Journal of Chemical & Engineering Data, 2024 | | 2024 |
| Binding of the B-Raf inhibitors dabrafenib and vemurafenib to human serum albumin: a biophysical and molecular simulation study M Russi, G Cavalieri, D Marson, E Laurini, S Pricl Molecular Pharmaceutics 19 (5), 1619-1634, 2022 | 8 | 2022 |
| Bioimaging: Surface charge of supramolecular nanosystems for in vivo biodistribution: A MicroSPECT/CT imaging study (small 37/2020) L Ding, Z Lyu, B Louis, A Tintaru, E Laurini, D Marson, M Zhang, W Shao, ... Small 16 (37), 2070203, 2020 | 1 | 2020 |
| Breast cancer nanomedicine market update and other industrial perspectives of nanomedicine S Aulic, D Marson, E Laurini, M Fermeglia, S Pricl Nanomedicines for Breast Cancer Theranostics, 371-404, 2020 | 20 | 2020 |
| Catch me if you can: ligand/antibody conjugated PAMAM dendrimer V Dal Col, E Laurini, P Posocco, D Marson, Q Wang, M Fermeglia, L Peng, ... 7e Rencontre de Chimie Organique de Marseille, 1-1, 2012 | | 2012 |
| Cationic carbosilane dendrimers and oligonucleotide binding: An energetic affair D Marson, E Laurini, P Posocco, M Fermeglia, S Pricl Nanoscale 7 (9), 3876-3887, 2015 | 16 | 2015 |
| Cationic dendrimers for siRNA delivery: an overview of methods for in vitro/in vivo characterization E Laurini, S Aulic, D Marson, M Fermeglia, S Pricl Design and Delivery of SiRNA Therapeutics, 209-244, 2021 | 7 | 2021 |
| Cationic Dendrimers for siRNA Delivery: Computational Approaches for Characterization D Marson, S Aulic, M Fermeglia, E Laurini, S Pricl Design and Delivery of SiRNA Therapeutics, 267-296, 2021 | | 2021 |
| Chemoenzymatic synthesis of 2, 6-disubstituted tetrahydropyrans with high σ1 receptor affinity, antitumor and analgesic activity N Kopp, G Civenni, D Marson, E Laurini, S Pricl, CV Catapano, HU Humpf, ... European Journal of Medicinal Chemistry 219, 113443, 2021 | 9 | 2021 |
| CLEAR! ComputationaL and Experimental design Rules in tailoring the monolayer organization of fluorocarbon/hydrocarbon thiolates mixtures on gold nanoparticles. D Marson, M Sologan, S Boccardo, P Pengo, S Pricl, L Pasquato, ... Royal Society of Chemistry, 2016 | | 2016 |
Sabrina PriclUniversity of Trieste在 di3.units.it 的电子邮件经过验证
